PL2310023T3 - Kompozycja zawierająca ekstrakt z zielonej herbaty i ekstrakt z granatów do stosowania w zapobieganiu lub ograniczeniu progresji raka prostaty - Google Patents

Kompozycja zawierająca ekstrakt z zielonej herbaty i ekstrakt z granatów do stosowania w zapobieganiu lub ograniczeniu progresji raka prostaty

Info

Publication number
PL2310023T3
PL2310023T3 PL09781009T PL09781009T PL2310023T3 PL 2310023 T3 PL2310023 T3 PL 2310023T3 PL 09781009 T PL09781009 T PL 09781009T PL 09781009 T PL09781009 T PL 09781009T PL 2310023 T3 PL2310023 T3 PL 2310023T3
Authority
PL
Poland
Prior art keywords
extract
prevention
reduction
composition containing
prostate cancer
Prior art date
Application number
PL09781009T
Other languages
English (en)
Inventor
Franco Gaetani
Ashraf Virmani
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of PL2310023T3 publication Critical patent/PL2310023T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PL09781009T 2008-07-31 2009-07-24 Kompozycja zawierająca ekstrakt z zielonej herbaty i ekstrakt z granatów do stosowania w zapobieganiu lub ograniczeniu progresji raka prostaty PL2310023T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08161516 2008-07-31

Publications (1)

Publication Number Publication Date
PL2310023T3 true PL2310023T3 (pl) 2017-02-28

Family

ID=39967972

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09781009T PL2310023T3 (pl) 2008-07-31 2009-07-24 Kompozycja zawierająca ekstrakt z zielonej herbaty i ekstrakt z granatów do stosowania w zapobieganiu lub ograniczeniu progresji raka prostaty

Country Status (19)

Country Link
US (2) US8758835B2 (pl)
EP (1) EP2310023B1 (pl)
JP (1) JP5564499B2 (pl)
KR (1) KR101621910B1 (pl)
CN (1) CN102112141B (pl)
AU (1) AU2009276035B2 (pl)
BR (1) BRPI0916435A8 (pl)
CA (1) CA2732205C (pl)
DK (1) DK2310023T3 (pl)
EA (1) EA019814B1 (pl)
ES (1) ES2602834T3 (pl)
HR (1) HRP20161447T1 (pl)
HU (1) HUE031821T2 (pl)
MX (1) MX2011000941A (pl)
MY (1) MY160546A (pl)
PL (1) PL2310023T3 (pl)
PT (1) PT2310023T (pl)
SG (2) SG10201700334XA (pl)
WO (1) WO2010012651A2 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2982460B1 (fr) 2011-11-14 2016-08-05 Virbac Sa Produits pour administration orale comprenant des extraits de grenade punica granatum, destines a un animal de compagnie, et ses applications
CN102652778A (zh) * 2012-03-29 2012-09-05 武汉华大药业有限公司 药物组合物
CN105796803A (zh) * 2014-12-30 2016-07-27 青岛加云华海健康科技有限公司 一种治疗和预防前列腺疾病的中药组合物及其制备和应用
CN108451979B (zh) * 2018-06-28 2020-04-28 新疆金骏阳光生物科技有限公司 一种具有辅助治疗前列腺癌的番茄红素复方制剂及其应用
JP7755840B2 (ja) * 2021-05-31 2025-10-17 株式会社東洋新薬 経口組成物
KR102514074B1 (ko) 2022-08-10 2023-03-27 (주)스마트푸릇 체내흡수율이 증가된 엘라그산과 갈산을 고함량 포함하는 혈관건강, 전립선 또는 성기능 개선용 석류 발효조성물 및 efc 공법을 이용한 그의 제조방법

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6030622A (en) * 1998-06-23 2000-02-29 Shehadeh; Ahmad Abdallah Herbal extract composition and method with immune-boosting capability
US20030086986A1 (en) * 1998-08-06 2003-05-08 Bruijn Chris De Ophthalmic, pharmaceutical and other healthcare preparations with naturally occurring plant compounds, extracts and derivatives
FR2791573B1 (fr) * 1999-03-30 2003-04-11 Pf Medicament Utilisation d'un extrait de serenoa repens pour la fabrication d'un medicament destine au traitement du cancer de la prostate
US6818234B1 (en) * 1999-08-27 2004-11-16 Access Business Group International Llc Dietary food supplement containing natural cyclooxygenase inhibitors and methods for inhibiting pain and inflammation
DE20009840U1 (de) * 2000-05-31 2000-08-24 Phyt-Immun GmbH, 66424 Homburg Nahrungsergänzungsmittel, Arzneimittel oder Arzneimittelbestandteil, jeweils enthaltend ein Schalotten/Öl-Mazerat
AUPR846401A0 (en) 2001-10-25 2001-11-15 Novogen Research Pty Ltd 6-Hydroxy isoflavones, derivatives and medicaments involving same
US8337914B2 (en) * 2002-02-27 2012-12-25 Access Business Group International Llc Dietary food supplement containing natural cyclooxygenase inhibitors and methods for inhibiting pain and inflammation
KR20030087566A (ko) * 2002-05-07 2003-11-14 액세스 비지니스 그룹 인터내셔날 엘엘씨 식물생리활성 영양 보조물
US6572899B1 (en) 2002-07-03 2003-06-03 Vitacost.Com, Inc. Memory loss treatment formulation
US20060251750A1 (en) * 2002-09-30 2006-11-09 Tabor Aaron T Soy formulations and their use in skin care
US8357945B2 (en) * 2002-12-27 2013-01-22 Momentive Performance Materials Inc. Gallium nitride crystal and method of making same
US20070248693A1 (en) * 2003-08-02 2007-10-25 Elizabeth Mazzio Nutraceutical composition and method of use for treatment / prevention of cancer
US20080038369A1 (en) * 2003-12-11 2008-02-14 Clark Ross G Methods And Compositions For The Treatment Of Prolactin-Receptor Related Disorders
WO2005095959A2 (en) * 2004-03-29 2005-10-13 Howard Murad Methods for treating dermatological conditions in a patient
US20060024385A1 (en) * 2004-07-27 2006-02-02 Pedersen Mark A Metabolic capacity enhancing compositions and methods for use in a mammal
US7776915B2 (en) * 2005-03-24 2010-08-17 Tracie Martyn International, Llc Topical formulations and methods of use
AU2006235266B2 (en) * 2005-04-07 2010-12-23 The Cleveland Clinic Foundation Gammaretrovirus associated with cancer
US7597910B2 (en) * 2005-08-20 2009-10-06 Slgm Medical Research Institute Compositions and methods for treating prostate disorders
DE202005020103U1 (de) * 2005-12-23 2006-04-27 China Vital Med E.K. Nahrungsergänzungsmittel
US20080031979A1 (en) * 2006-08-04 2008-02-07 Claude Saliou Use of extracts for the treatment of viral disorders
CN101646433B (zh) * 2006-10-24 2011-11-16 戴维·W·克雷姆平 抗再吸收的和造骨的食物增补剂和使用方法
US7927633B2 (en) * 2008-03-28 2011-04-19 Janiece Diane Swilling Adaptogenic tea

Also Published As

Publication number Publication date
EA201170269A1 (ru) 2011-06-30
SG192527A1 (en) 2013-08-30
MY160546A (en) 2017-03-15
US8758835B2 (en) 2014-06-24
AU2009276035B2 (en) 2015-10-01
BRPI0916435A2 (pt) 2016-02-16
JP5564499B2 (ja) 2014-07-30
SG10201700334XA (en) 2017-03-30
WO2010012651A2 (en) 2010-02-04
AU2009276035A1 (en) 2010-02-04
ES2602834T3 (es) 2017-02-22
HRP20161447T1 (hr) 2016-12-16
PT2310023T (pt) 2016-11-22
EA019814B1 (ru) 2014-06-30
CN102112141A (zh) 2011-06-29
EP2310023B1 (en) 2016-10-12
WO2010012651A3 (en) 2010-04-01
CA2732205A1 (en) 2010-02-04
CN102112141B (zh) 2013-03-06
DK2310023T3 (en) 2016-12-12
US20140255512A1 (en) 2014-09-11
JP2011529465A (ja) 2011-12-08
HK1158076A1 (en) 2012-07-13
HUE031821T2 (en) 2017-08-28
KR20110043615A (ko) 2011-04-27
CA2732205C (en) 2018-01-02
US9084812B2 (en) 2015-07-21
KR101621910B1 (ko) 2016-05-17
BRPI0916435A8 (pt) 2017-12-26
EP2310023A2 (en) 2011-04-20
MX2011000941A (es) 2011-03-29
US20110262417A1 (en) 2011-10-27

Similar Documents

Publication Publication Date Title
LT2556071T (lt) Kinazės inhibitoriai ir jų panaudojimas vėžio gydymui
IL212960A (en) Sulfonamide derivatives, the vehicle containing them and their use in cancer treatment
IL218169A (en) Quinazoline compounds and their pharmaceutical compositions containing them for use in therapy
SI2483278T1 (sl) Inhibitorske spojine benzoksazepina pi3k in njihova uporaba pri zdravljenju raka
SI2172211T1 (sl) Sestavek s tumorjem povezanih peptidov in zadevnih cepiv proti raku za zdravljenje glioblastoma (GBM) in drugih vrst raka
PL2340042T3 (pl) Sposoby i kompozycje do leczenia raka
EP2211854A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER USING BENZOPYRONE-TYPE PARP INHIBITORS
IL219253A (en) Benzodiazepine inhibiting bromodomain for cancer treatment
IL212834A (en) Preparations containing 37cd-specific linkers, for use in the treatment of B cell or autoimmune cancer and kits
PT2451279T (pt) Derivados de benzosulfonamida, composições dos mesmos, e uso dos mesmos na prevenção de metástases de células cancerígenas
IL206970A0 (en) Compositions and methods for the treatment of tumor of hematopoietic origin
SG10201509279QA (en) Compositions and methods for the prevention and treatment of cancer
IL214626A0 (en) Prodrug forms of kinase inhibitors and their use in therapy
IL218287A0 (en) Use of metformin in cancer treatment and prevention
PL2632452T3 (pl) Związki i kompozycje stosowane w leczeniu nowotworów
BR112012005774B8 (pt) uso de um inibidor de quinase antiangiogênico no tratamento de câncer
EP2334312A4 (en) COMPOSITIONS COMPRISING PLANT EXTRACTS AND THEIR USE FOR TREATING INFLAMMATION
EP2320921A4 (en) COMPOSITIONS WITH TEA TREE OIL AND METHOD FOR THE PREVENTION AND TREATMENT OF CANCER
IL215772A (en) The vehicle containing Degarelix for use in prostate cancer treatment
IL197909A0 (en) Reduction of astringency in polyphenol compositions
EP2231185A4 (en) METHOD AND COMPOSITIONS FOR TREATING LIQUID TUMORS
IL214349A0 (en) Compositions and methods for the treatment of cancer
PL2310023T3 (pl) Kompozycja zawierająca ekstrakt z zielonej herbaty i ekstrakt z granatów do stosowania w zapobieganiu lub ograniczeniu progresji raka prostaty
EP2651894A4 (en) THIOSEMICARBAZONE COMPOUNDS FOR CANCER TREATMENT
EP2176406A4 (en) COMPOSITIONS AND METHOD FOR CANCER TREATMENT